Literature DB >> 24129047

Interferon beta 1a anaphylaxis, a case report. Standardization of non-irritating concentration for allergy skin tests.

G Cortellini1, A Amadori, T Comandini, A Corvetta.   

Abstract

Multiple sclerosis is a disease with a potentially severe prognosis and epidemiologically increasing. Interferon beta 1a is a very useful maintenance therapy widely used by neurologists. In the literature, there are several case reports of  hypersensitivity reactions. In this case report we describe an anaphylactic IgE mediated reaction to interferon beta 1a. We also describe, for the first time in the medical literature, the non-irritating concentration (NIC) to be used for skin tests.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24129047

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  2 in total

1.  Protracted anaphylaxis developed after peginterferon α-2a administration for chronic hepatitis C.

Authors:  Akihiko Sakatani; Yoshinori Doi; Takaaki Matsuda; Yasutaka Sasai; Naohiro Nishida; Megumi Sakamoto; Naoto Uenoyama; Yoshiya Matsumoto; Kazuo Kinoshita
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

2.  Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper.

Authors:  Aslı Gelincik; Knut Brockow; Gülfem E Çelik; Inmaculada Doña; Cristobalina Mayorga; Antonino Romano; Özge Soyer; Marina Atanaskovic-Markovic; Annick Barbaud; Maria Jose Torres
Journal:  Allergy       Date:  2020-07-01       Impact factor: 14.710

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.